Citi Comments On GSK

Symbols: GSK
Tags: Citi
Share

According to Citi, GlaxoSmithKline (NYSE: GSK), Hold position is reiterated.

Citi announced that they will be maintaining their Hold/Low-Risk position on GSK. PT is set at $41.17.

GSK closed on Friday at $43.75


 
 
< Previous
Morgan Stanley Comments On Whole Foods
Next >
Disclosure Insight Changes Rating On Ruby Tuesday
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust